Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 32,528 | 21,351 | 18,730 | 18,276 | 9,576 |
| Cost of Goods | 14,107 | 10,697 | 8,551 | 6,722 | 5,069 |
| Gross Profit | 18,421 | 10,654 | 10,179 | 11,554 | 4,507 |
| Operating Expenses | 18,956 | 16,421 | 14,212 | 11,358 | 9,588 |
| Operating Income | -428 | -5,070 | -3,482 | 918 | -5,012 |
| Other Income | 60 | -501 | -43 | -5,386 | 27 |
| Pre-tax Income | -368 | -5,571 | -3,525 | -4,468 | -4,985 |
| Income Tax | 43 | 36 | -1,015 | 920 | N/A |
| Net Income Continuous | -411 | -5,607 | -2,510 | -5,388 | -4,985 |
| Net Income Discontinuous | N/A | N/A | N/A | 41 | -3,329 |
| Net Income | $-411 | $-5,607 | $-2,510 | $-5,347 | $-8,314 |
| EPS Basic Total Ops | -0.02 | -0.31 | -0.14 | -1.00 | -0.61 |
| EPS Basic Continuous Ops | -0.02 | -0.31 | -0.14 | -0.39 | -0.42 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | -0.28 |
| EPS Diluted Total Ops | -0.02 | -0.31 | -0.14 | -1.00 | -0.61 |
| EPS Diluted Continuous Ops | -0.02 | -0.31 | -0.14 | -0.39 | -0.42 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.00 | -0.28 |
| EPS Diluted Before Non-Recurring Items | 0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,785 | $-2,610 | $-1,384 | $2,151 | $-4,437 |